BUKWANG PHARMACEUTICAL CO LTD has a total of 14 patent applications. Its first patent ever was published in 1994. It filed its patents most often in EPO (European Patent Office), Israel and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ARTHROSI THERAPEUTICS INC, VERTEX PHARMACEUTICALS EUROPE LTD and UNICEL LAB CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | Israel | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Hong Kong | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Organic chemistry methods | |
#5 | Sugars | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Lee Kwang Ok | 7 |
#2 | Jeong Eun Ju | 7 |
#3 | Lee Kyung Hwa | 7 |
#4 | Lee Jun | 1 |
#5 | Lee Sung-Koo | 1 |
#6 | Lee Young Hun | 1 |
#7 | Sznaidman Marcos | 1 |
#8 | Han Young Tae | 1 |
#9 | Yoon Jeong Hyeok | 1 |
#10 | Kyung Hwa Lee | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018139883A1 | Fused pyrimidine derivative as multi-target kinase inhibitor | |
WO2019139185A1 | Method for preparing tolimidone on large scale | |
EP1150995A1 | A synthetic peptide disturbing intracellular signaling | |
KR0128854B1 | Liver trouble treatment agent comprising sylimarim and colchi cine and process for preparation thereof |